(A) Averaged sIPSCs from all nRT cells recorded from wild-type (n=23 cells) and α3(H126R) mice (n=20 cells) at P4–14, normalized to peak amplitude. (B) Probability distributions for >1,500 events/group comparing sIPSC half width in WT vs. α3(H126R). (C) Averaged eIPSC traces across all nRT cells recorded from WT mice (black trace) and α3(H126R) mutant mice (blue trace) at P14–21, normalized to peak amplitude. Black dot indicates time of electrical stimulation applied to nRT (stimulus artifact removed for clarity). (D) Mean + SEM for eIPSC half width in WT (black bar, n=22 cells) and α3(H126R) mutant mice (blue bar, n=10 cells). (E) Mean amplitude versus mean variance of sIPSCs from example WT (black) and α3(H126R) (blue) nRT cells. The curve fit is to the parabolic function: σ²−σ²_Noise = iI_m − I²_m/N. (F–G) Mean + SEM for unitary conductance (γ) (F, p>0.8) and number of channels mediating sIPSC events (G, p>0.4). (H) Averaged uncaged IPSC traces for nRT patches from WT (black trace, n=8 patches) and α3(H126R) mutant mice (blue trace, n=5 patches) at P21. hν symbol indicates time of 1 ms UV laser stimulus. (I–J) Mean + SEM for uncaged IPSC half width (I; p>0.5) and 90–10% decay time (J; p>0.3). Note that in contrast to the sniffer patch experiments presented in , here the patches were positioned in the superfusion solution >100 µm above the slice to eliminate the influence of endogenous modulators. **p<0.01, ***p<0.001 vs. WT. See also .

(A) Representative traces recorded in individual nRT and VB cells before and during FLZ treatment. (B) Averaged sIPSCs in individual nRT and VB cells before and during FLZ treatment, normalized to peak amplitude. (C) sIPSC half width in nRT (n=13) and VB (n=17) cells before (Con) and during FLZ treatment at P4–14. Open boxes indicate mean ± SEM. (D) Averaged eIPSC traces in a representative nRT cell before (Control, black trace) and during FLZ treatment (FLZ, red trace). (E) eIPSC half width in individual WT nRT cells (n=8) before (Con), during (FLZ), and after (Wash) FLZ treatment recorded at P19–22. Open boxes indicate mean ± SEM during control, FLZ, and washout conditions. (F) Averaged traces of sIPSCs recorded in a representative α3(H126R) nRT cell before and during FLZ treatment, normalized to peak amplitude. (G) sIPSC half width in α3(H126R) nRT cells (n=10) before (Con) and during FLZ treatment at P4–14. Open boxes indicate mean ± SEM. *p<0.05, ***p<0.001 vs. Con. See also .

(A) Averaged sIPSC traces from nRT cells in control conditions (n=14 cells) and cells preincubated and recorded in finasteride (n=13 cells) recorded at ages P17–25, normalized to peak amplitude. (B) Probability distributions for >1,300 events per group comparing sIPSC half width in control (black line) vs. finasteride conditions (purple line). (C) sIPSC half width in individual nRT cells in control (n=10) or finasteride conditions (n=9) before (Con) and during (FLZ) in vitro FLZ treatment. Open boxes indicate mean ± SEM. (D) Mean + SEM for percentage change in sIPSC half width in response to FLZ in control and finasteride conditions. ***p<0.001 vs. Control (B,C); ns, not significant.

(A) Representative averaged traces of sIPSCs recorded in an individual WT nRT cell under control conditions (black trace), after 10 min bath application of 100 nM clonazepam (CZP, gray trace), and in CZP with subsequent 10 min bath application of FLZ (CZP+FLZ, red trace), normalized to peak amplitude. (B) sIPSC half width in individual WT nRT cells (n=8) at P20–29 in control conditions (Con), during CZP treatment (CZP), and during subsequent FLZ treatment (CZP+FLZ). Open boxes indicate mean ± SEM during control (black), CZP (gray), and CZP+FLZ conditions (red). (C) Mean + SEM for percentage change in sIPSC half width from control to CZP conditions (gray bar), CZP to CZP+FLZ conditions (red bar), and from control to CZP+FLZ conditions (black bar). (D) Mean + SEM for the within-cell ratio of the percentage change from control to CZP+FLZ conditions compared to the percentage change from CZP alone to CZP+FLZ. (E) Averaged sIPSC traces from control VB cells (black trace) and cells in slices either preincubated in 100 nM clonazepam (CZP, gray trace), or in CZP with subsequent 10 min bath application of FLZ (CZP+FLZ, red trace). Note that FLZ treatment does not reduce sIPSC duration past control values, as compared to nRT cells. (F) Probability distribution for >800 events per group comparing sIPSC half width in control (black line, n=8) and CZP-preincubated cells (gray line, n=11). **p<0.01, ***p<0.001 vs. Control (B, F), ###p<0.001 vs. CZP (B).

(A–B) Fluorescence images illustrating immunocytochemical staining for DBI and the nucleic acid marker DAPI in striatum and thalamus in WT (A) and nm1054 (B) mice. Dotted and dashed lines indicate approximate borders of striatum (Str), internal capsule (IC), and thalamic nuclei. Averaged sIPSCs from nRT cells recorded from WT (n=14 cells) and nm1054 mice (n=13 cells) at P22–29, normalized to peak amplitude. (D) Probability distributions (>1300 events/group) comparing sIPSC half width. (E) GFP fluorescence in mouse thalamus injected with AAV-DBI-GFP vector. (F–H) DBI and GFP staining in nRT of nm1054 mice injected with control AAV-GFP (F) or AAV-DBI-GFP vector (G–H). (I) Probability distributions (>800 events/group) comparing sIPSC half width. (J) sIPSC half width in nRT cells from WT mice injected with control AAV-GFP (left, n=7 cells), and nm1054 mice injected with AAV-GFP (middle, n=7) or AAV-DBI-GFP vector (right, n=11) before (Con) and during FLZ treatment. Open boxes indicate mean ± SEM. (K) Mean + SEM for percentage change in sIPSC half width in response to FLZ. Calibration: 100 µm (A–B); 200 µm (E); 25 µm (F–H). **p<0.01, ***p<0.001 vs. WT (D, I, K) or Con (J); ##p<0.01, ###p<0.001 vs. nm1054 AAV-DBI-GFP (I, K). See also .

(A) Uncaged GABA IPSC responses averaged across all outside-out patches pulled from VB neurons recorded when patches were placed in VB or nRT, normalized to peak amplitude. Inset, proof-of-principle experiment demonstrating potentiation of averaged responses recorded from the same patch first placed in VB (1) and then moved to nRT (2), normalized to peak amplitude. Similar results were obtained in 3 other patches. (B) Responses averaged across all WT patches in the presence of FLZ, normalized to peak amplitude. (C) Responses averaged across all patches recorded in slices from nm1054 mice, normalized to peak amplitude. Inset, schematic illustrating movement of patch pipette from VB to nRT. (D) Responses averaged across all nm1054 patches in the presence of FLZ, normalized to peak amplitude. Inset, averaged traces for responses recorded when patches were placed in nRT, re-plotted from A–D for clarity. (E) Mean + SEM for 90–10% decay time of responses. Colored bars for patches placed in nRT are all significantly different from WT control, but are not significantly different from each other (P>0.9). Each bar represents 6–8 patches. There was no difference for patches in VB (P>0.8). FIN – finasteride. hν symbol – 1 ms laser stimulus. *p<0.05, **p<0.01, ***p<0.001 vs. respective values for patches placed in VB; #p<0.05, ##p<0.01 vs. WT in nRT. See also .

(A–B) Example traces of spontaneous SWDs recorded from α3(H126R) mice and respective WT (A) and nm1054 mice and respective WT (B). Note that SWD amplitude (power) was not significantly different between groups (p>0.2). Therefore, examples were chosen to illustrate typical SWD waveforms in each condition, which were not affected by SWD power. (C–D) Mean + SEM for spontaneous 4–6 Hz SWD rate and percentage of time spent in spontaneous SWD activity in WT (n=17) and α3(H126R) mice (n=9) (C) and WT (n=7) and nm1054 mice (n=4) (D). (E–F) Mean ± SEM for SWD period over time following PTZ injection (Time 0, 40 mg/kg) in WT (n=7) and α3(H126R) mice (n=4) (E) and WT (n=7) and nm1054 mice (n=4) (F). (G–H) Linear regression of lines of best fit for points plotted in (EF) shows positive correlations (i.e., SWD slowing) with time after PTZ injection in WT, but not in α3(H126R) nor nm1054 mice. **p<0.01, ***p<0.001 vs. WT; ##p<0.01, ###p<0.001 - repeated measures ANOVA (E–F) or Pearson correlation (G–H) across 1-min bins after PTZ injection. Gray bars in E–F indicate times at which values differed between mutants and controls (p<0.05). See also .